After-Hours Stock Movers:Quanterix, Relay Therapeutics, Matson and more

StreetInsider2021-10-12

After-Hours Stock Movers: Quanterix Corp 20.4% HIGHER; announced today that its Simoa® phospho-Tau 181 (pTau-181) blood test has been granted Breakthrough Device designation by the U.S. Food and Drug ...

网页链接
免责声明:本文观点仅代表作者个人观点,不构成本平台的投资建议,本平台不对文章信息准确性、完整性和及时性做出任何保证,亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

  • Deonc
    2021-10-12
    Deonc
    like and comment, please
    • JeremyKok
      hi. please like and comment back. thank you.
    • Deonc
      done, thanks
  • HENRYCSC
    2021-10-12
    HENRYCSC
    Like pls
    • JeremyKok
      hi. please like and comment back. thank you.
  • breAkdaWn
    2021-10-12
    breAkdaWn
    AD makes a person like a living vegetable. So many people suffering from it. More so for the people taking care of the AD person I know this very well. Come on science get the cure and  prevention quickly.
  • koolgal
    2021-10-12
    koolgal
    Any medical device that aids in the speedy diagnosis of Alzheimer Disease will be a big step in medical advancement and lead to early treatment of the dreaded disease.   I will put Quanterix on my watch list. 👍😊
    • 滚股怪
      Like
    • JeremyKok
      at what stage is their Alzheimer's disease testing at? buy it during their final testing phase before FDA approval. if it is still at early stage you are just buying on hope.
    • koolgal
      That is a great question.  Not sure about that.  Buying on hope is not a good idea I agree. 👍😊
    • koolgal
      Great idea.  Thanks for sharing 👍😊
    • YaleBrewster
      Pharmaceutical stocks are suitable for long-term holding
  • JaiVenky
    2021-10-12
    JaiVenky
    Nice
  • KongSH
    2021-10-12
    KongSH
    Wishing everyone another day of gain in investment… Huat Ah!!! 😄😄
发表看法
22